Quality of life outcomes from a dose-per-fraction escalation trial of hypofractionation in prostate cancer.

about

Optimal number and sizes of the doses in fractionated radiotherapy according to the LQ model.

P2860

Q47560995-9BFEFC7E-CD54-4C0C-B41E-289BE1FE330F

P2860

Quality of life outcomes from a dose-per-fraction escalation trial of hypofractionation in prostate cancer.

Item

http://www.wikidata.org/entity/Q38603388

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Quality of life outcomes from ...... ctionation in prostate cancer.

@en

type

Item

label

Quality of life outcomes from ...... ctionation in prostate cancer.

@en

prefLabel

Quality of life outcomes from ...... ctionation in prostate cancer.

@en

P1476

Quality of life outcomes from ...... ctionation in prostate cancer.

@en

P2093

Colleen A Lawton

http://www.w3.org/2001/XMLSchema#string

Daniel G Petereit

http://www.w3.org/2001/XMLSchema#string

Jeffrey D Forman

http://www.w3.org/2001/XMLSchema#string

Jeffrey V Brower

http://www.w3.org/2001/XMLSchema#string

Mark A Ritter

http://www.w3.org/2001/XMLSchema#string

Nick Anger

http://www.w3.org/2001/XMLSchema#string

Patrick A Kupelian

http://www.w3.org/2001/XMLSchema#string

Rick Chappell

http://www.w3.org/2001/XMLSchema#string

Sandeep Saha

http://www.w3.org/2001/XMLSchema#string

Vinai Gondi

http://www.w3.org/2001/XMLSchema#string

P2860

Quality of life study in prostate cancer patients treated with three-dimensional conformal radiation therapy: comparing late bowel and bladder quality of life symptoms to that of the normal population.

Is alpha/beta for prostate tumors really low?

Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial

Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer.

Hypofractionation for clinically localized prostate cancer.

A systematic review of hypofractionation for primary management of prostate cancer.

Stereotactic body radiotherapy for low-risk prostate cancer: five-year outcomes.

Comparison of quality of life after stereotactic body radiotherapy and surgery for early-stage prostate cancer.

Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 years.

P304

99-104

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.RADONC.2015.12.018

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26755165

http://www.w3.org/2001/XMLSchema#string

P932

4764419

http://www.w3.org/2001/XMLSchema#string

Quality of life outcomes from a dose-per-fraction escalation trial of hypofractionation in prostate cancer.

about

P2860

P2860

Quality of life outcomes from a dose-per-fraction escalation trial of hypofractionation in prostate cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932